Topical Application of Agents to Affect Neutrophil Migration Across Polarized Epithelial Barriers
- Detailed Technology Description
- This invention provides topical agents that reduce inflammation by opposing the pro-inflammatory MRP2 system and by utilizing an endocannabinoid system. Increasing the activity of the CB2 endocannabin
- Countries
- Not Available
- Application No.
- None
- *Abstract
-
This invention provides topical agents that reduce inflammation by opposing the pro-inflammatory MRP2 system and by utilizing an endocannabinoid system. Increasing the activity of the CB2 endocannabinoid pathway can suppress local neutrophil migration consequentially result in anti-inflammation.
- *IP Issue Date
- None
- *IP Type
- Other Patent
- Country/Region
- USA

For more information, please click Here